|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.605 USD | +3.04% |
|
+3.06% | +36.34% |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Growth Benchmark | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 7.26 | 7.86 | 7.64 |
| Spread/Res. | -9.29% | -16.22% | -13.80% |
| Spread/Supp. | +15.13% | +27.62% | +227.63% |
| Support | 5.72 | 5.16 | 2.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RLMD Stock
- Charts Relmada Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
